Cardiovascular Bioengineering (CVBE) Symposium - 2019

心血管生物工程 (CVBE) 研讨会 - 2019

• 批准号: 9763289
• 负责人: JOEL L BERRY
• 金额: $ 1.26万
• 依托单位: UNIVERSITY OF ALABAMA AT BIRMINGHAM
• 依托单位国家: 美国
• 财政年份: 2019
• 资助国家: 美国
• 起止时间: 2019-03-01 至 2020-02-29
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/9763289
• 关键词: Alabama; Anniversary; Area; Australia; Award; Berry; Biological Sciences; Biomedical Engineering; Cardiac; Cardiac development; Cardiovascular system; Cell Maturation; Cell Therapy; Cells; Collaborations; Communities; Engineering; Ensure; Equilibrium; Functional disorder; Future; Genes; Goals; Grant; Heart Diseases; Heart failure; Hip region structure; Individual; Learning; Life; Medical Research; Metabolic; MicroRNAs; Minority; Mitochondria; Molecular; National Heart, Lung, and Blood Institute; Pluripotent Stem Cells; Regenerative Medicine; Request for Proposals; Research; Research Personnel; Science; Scientist; Stem cells; Tissue Engineering; Travel; Underrepresented Minority; United States National Institutes of Health; Universities; Videotape; Work; cardiac tissue engineering; career; combat; cost; design; epigenetic regulation; exosome; experience; induced pluripotent stem cell; lectures; medical specialties; meetings; minority investigator; molecular targeted therapies; next generation; novel; novel therapeutics; outreach; posters; programs; recruit; stem cell differentiation; success; symposium

Project Summary This is a new application to support efforts to increase involvement of trainees and junior scientists for the 2019 Cardiovascular Bioengineering Symposium (CVBE) to be held on the campus of The University of Sydney, Australia. This will be the 4th Anniversary of the Symposium. The uniqueness of the CVBE symposium lies in its combination of top researchers in cardiovascular bioengineering, trainees, junior investigators, and underrepresented minorities. The symposium will provide a forum for trainees, junior and minority investigators to interact with world's leading scientists as they present their work. This work reflects the convergence of life sciences and engineering in the areas of gene editing, induced pluripotent stem cells, and cardiac stem cells in the context of heart failure as well general topics in cardiovascular bioengineering. This conference has previously been held separately from (but in conjunction with) the NIH NHLBI progenitor cell translational consortium (NIH PCTC) for the past 3 years1, 2, 3, 4 by The University of Alabama at Birmingham (UAB). The meeting became an annual public symposium in 2016, and since then, this conference has been recognized as a unique public and recurring scientific symposium of stem cell and cardiovascular bioengineering. The conference in recent 2 years has added translational topics as well as the “bread and butter” of this meeting, which is basic stem cell bioengineering, molecular cardiovascular research, and tissue engineering. The conference has attracted the world's leading scientists in field of cardiac stem cells.1, 2, 3, 4 The original conference topics started with tissue engineering, hiPS cells, cardiac development, and recent two years has grown to include exosome, microRNAs, mitochondria, cardiac gene and cardiac cell therapy. The attendance of this conference has climbed and, in 2018, we had attendance of over 200. As in past years, the conference will be held in late February/early March, and this year, will be held March 1-2 at The University of Sydney. The planned agenda represents an ambitious, fast-paced meeting with 8 sessions in 1.5 days including the Keynote lecture. Young cardiovascular scientists will be highlighted through invited talks at each session. Organizers of this meeting are Drs. Jianyi (Jay) Zhang (UAB), James Chong (U of Sydney), Gangjian Qin (UAB), and Joel Berry (UAB). This proposal requests $10,000, and as we have done over the last several years, the support will be used towards the cost of trainee travel, trainee poster session awards, meeting supplies, and support for videotaping all sessions.

项目摘要 这是一个新的应用程序，以支持增加2019年受训人员和初级科学家参与的努力 心血管生物工程研讨会（CVBE）将在悉尼大学校园举行， 澳大利亚这将是研讨会的第四周年。CVBE研讨会的独特之处在于， 心血管生物工程领域的顶尖研究人员、受训人员、初级研究人员和 代表性不足的少数民族。专题讨论会将为受训人员、初级和少数民族调查人员提供一个论坛 与世界领先的科学家互动，因为他们介绍了他们的工作。这件作品反映了生活的趋同 基因编辑、诱导多能干细胞和心脏干细胞领域的科学和工程 心力衰竭的背景以及心血管生物工程的一般主题。本次会议 先前与NIH NHLBI祖细胞翻译分开（但与NIH NHLBI祖细胞翻译结合） 财团（NIH PCTC）在过去3年1，2，3，4由伯明翰的亚拉巴马大学（UAB）。的 会议于2016年成为年度公共研讨会，从那时起，该会议已被公认为 一个独特的公共和经常性的干细胞和心血管生物工程科学研讨会。的 近2年的会议增加了翻译主题以及本次会议的“面包和黄油”， 就是基础干细胞生物工程，分子心血管研究，组织工程。的 会议吸引了心脏干细胞领域的世界领先科学家。1，2，3，4 会议主题从组织工程、hiPS细胞、心脏发育开始，近两年 包括外泌体、微小RNA、线粒体、心脏基因和心脏细胞疗法。之出席情况 这个会议已经攀升，在2018年，我们有超过200人参加。与往年一样，会议将 将于2月底/3月初举行，今年将于3月1日至2日在悉尼大学举行。的 计划的议程代表了一个雄心勃勃的，快节奏的会议，在1.5天内举行了8次会议，包括主题演讲 讲座年轻的心血管科学家将通过邀请在每届会议上的谈话突出。组织者 参加本次会议的有Jianyi（Jay）Zhang（UAB）、James Chong（悉尼大学）、Gangjian Qin（UAB）和Joel Berry（UAB）.这项提案要求1万美元，正如我们在过去几年所做的那样， 将用于培训生差旅费、培训生海报会议奖励、会议用品，以及 支持对所有会议进行录像。